
PathWhiz ID | Pathway | Meta Data |
---|---|---|
PW145376 |
drug action
Cefonicid Drug Metabolism Action PathwayHomo sapiens
|
Creator: Ray Kruger Created On: October 07, 2023 at 15:41 Last Updated: October 07, 2023 at 15:41 |
PW175993 |
Cefonicid Predicted Metabolism Pathway newHomo sapiens
Metabolites of Cefonicid are predicted with biotransformer.
|
Creator: Omolola Created On: November 29, 2023 at 13:04 Last Updated: November 29, 2023 at 13:04 |
PW176944 |
drug action
Cefoperazone Action PathwayEscherichia coli
Cefoperazone is a broad-spectrum cephalosporin antibiotic used for the treatment of bacterial infections in various locations, including the respiratory tract, abdomen, skin, and female genital tracts. Cefoperazone exhibits a bactericidal mode of action. It works by binding to and inhibiting bacterial penicillin-binding proteins (PBPs). Upon binding to PBPs, ertapenem inhibits bacterial cell wall synthesis by interfering with the lengthening and strengthening of the peptidoglycan portion of the cell wall, thereby inhibiting cell wall synthesis.
|
Creator: Karxena Harford Created On: January 02, 2024 at 09:18 Last Updated: January 02, 2024 at 09:18 |
PW145377 |
drug action
Cefoperazone Drug Metabolism Action PathwayHomo sapiens
|
Creator: Ray Kruger Created On: October 07, 2023 at 15:42 Last Updated: October 07, 2023 at 15:42 |
PW175994 |
Cefoperazone Predicted Metabolism Pathway newHomo sapiens
Metabolites of Cefoperazone are predicted with biotransformer.
|
Creator: Omolola Created On: November 29, 2023 at 13:05 Last Updated: November 29, 2023 at 13:05 |
PW176958 |
drug action
Ceforanide Action PathwayEscherichia coli
Ceforanide is a 1-β methyl-carbapenem that is structurally related to beta-lactam antibiotics.5 It was first authorized for use in the US in November 2001 and in Europe in April 2002. Shown to be effective against a wide range of Gram-positive and Gram-negative aerobic and anaerobic bacteria, ertapenem is used to treat various bacterial infections. Ceforanide exhibits a bactericidal mode of action. It works by binding to and inhibiting bacterial penicillin-binding proteins (PBPs).5 In Escherichia coli, it has a strong affinity toward PBPs 1a, 1b, 2, 3, 4 and 5 with preferential binding to PBPs 2 and 3.5 Upon binding to PBPs, ertapenem inhibits bacterial cell wall synthesis by interfering with the lengthening and strengthening of the peptidoglycan portion of the cell wall, thereby inhibiting cell wall synthesis.
|
Creator: Karxena Harford Created On: January 02, 2024 at 09:20 Last Updated: January 02, 2024 at 09:20 |
PW145024 |
drug action
Ceforanide Drug Metabolism Action PathwayHomo sapiens
|
Creator: Ray Kruger Created On: October 07, 2023 at 14:56 Last Updated: October 07, 2023 at 14:56 |
PW175995 |
Ceforanide Predicted Metabolism Pathway newHomo sapiens
Metabolites of Ceforanide are predicted with biotransformer.
|
Creator: Omolola Created On: November 29, 2023 at 13:05 Last Updated: November 29, 2023 at 13:05 |
PW126769 |
drug action
Cefotaxime Action PathwayStreptococcus pneumoniae (strain ATCC BAA-255 / R6)
Cefotaxime is a third-generation cephalosporin used to treat susceptible gram-negative and gram-positive bacterial infections. It is used to treat gonorrhea, meningitis, and severe infections including infections of the kidney (pyelonephritis) and urinary system. Also used before an operation to prevent infection after surgery.
action
The bactericidal activity of cefotaxime results from the inhibition of cell wall synthesis via affinity for penicillin-binding proteins (PBPs).
Penicillin binding proteins are responsible for glycosyltransferase and transpeptidase reactions that lead to cross-linking of D-alanine and D-aspartic acid in bacterial cell walls. Inhibition of this protein leads to upregulation of autolytic enzymes and inhibition of cell wall synthesis. Cefotaxime is bactericidal and kills off the bacteria that it affects.
|
Creator: Karxena Harford Created On: March 23, 2022 at 03:06 Last Updated: March 23, 2022 at 03:06 |
PW144615 |
drug action
Cefotaxime Drug Metabolism Action PathwayHomo sapiens
|
Creator: Ray Kruger Created On: October 07, 2023 at 14:02 Last Updated: October 07, 2023 at 14:02 |